2018-2023 Global Live Attenuated Vaccines Consumption Market Report

October 2018 | 138 pages | ID: 2037C3D1FAAEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Live Attenuated Vaccines market for 2018-2023.

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or 'live'). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by 'killing' the virus (inactivated vaccine).
Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.
Over the next five years, LPI(LP Information) projects that Live Attenuated Vaccines will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Vaccines market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Bacterial
• Viral

Segmentation by application:

• Hospitals
• Clinics
• Research Institutes
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• GlaxoSmithKline
• Merck
• Pfizer
• Astellas Pharma
• Johnson & Johnson
• CSL
• Sanofi
• Serum Institute Of India

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Live Attenuated Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Live Attenuated Vaccines market by identifying its various subsegments.
• Focuses on the key global Live Attenuated Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Live Attenuated Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Live Attenuated Vaccines submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Live Attenuated Vaccines Consumption 2013-2023
  2.1.2 Live Attenuated Vaccines Consumption CAGR by Region
2.2 Live Attenuated Vaccines Segment by Type
  2.2.1 Bacterial
  2.2.2 Viral
2.3 Live Attenuated Vaccines Consumption by Type
  2.3.1 Global Live Attenuated Vaccines Consumption Market Share by Type (2013-2018)
  2.3.2 Global Live Attenuated Vaccines Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Live Attenuated Vaccines Sale Price by Type (2013-2018)
2.4 Live Attenuated Vaccines Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Research Institutes
  2.4.4 Others
2.5 Live Attenuated Vaccines Consumption by Application
  2.5.1 Global Live Attenuated Vaccines Consumption Market Share by Application (2013-2018)
  2.5.2 Global Live Attenuated Vaccines Value and Market Share by Application (2013-2018)
  2.5.3 Global Live Attenuated Vaccines Sale Price by Application (2013-2018)

3 GLOBAL LIVE ATTENUATED VACCINES BY PLAYERS

3.1 Global Live Attenuated Vaccines Sales Market Share by Players
  3.1.1 Global Live Attenuated Vaccines Sales by Players (2016-2018)
  3.1.2 Global Live Attenuated Vaccines Sales Market Share by Players (2016-2018)
3.2 Global Live Attenuated Vaccines Revenue Market Share by Players
  3.2.1 Global Live Attenuated Vaccines Revenue by Players (2016-2018)
  3.2.2 Global Live Attenuated Vaccines Revenue Market Share by Players (2016-2018)
3.3 Global Live Attenuated Vaccines Sale Price by Players
3.4 Global Live Attenuated Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Live Attenuated Vaccines Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Live Attenuated Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 LIVE ATTENUATED VACCINES BY REGIONS

4.1 Live Attenuated Vaccines by Regions
  4.1.1 Global Live Attenuated Vaccines Consumption by Regions
  4.1.2 Global Live Attenuated Vaccines Value by Regions
4.2 Americas Live Attenuated Vaccines Consumption Growth
4.3 APAC Live Attenuated Vaccines Consumption Growth
4.4 Europe Live Attenuated Vaccines Consumption Growth
4.5 Middle East & Africa Live Attenuated Vaccines Consumption Growth

5 AMERICAS

5.1 Americas Live Attenuated Vaccines Consumption by Countries
  5.1.1 Americas Live Attenuated Vaccines Consumption by Countries (2013-2018)
  5.1.2 Americas Live Attenuated Vaccines Value by Countries (2013-2018)
5.2 Americas Live Attenuated Vaccines Consumption by Type
5.3 Americas Live Attenuated Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Live Attenuated Vaccines Consumption by Countries
  6.1.1 APAC Live Attenuated Vaccines Consumption by Countries (2013-2018)
  6.1.2 APAC Live Attenuated Vaccines Value by Countries (2013-2018)
6.2 APAC Live Attenuated Vaccines Consumption by Type
6.3 APAC Live Attenuated Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Live Attenuated Vaccines by Countries
  7.1.1 Europe Live Attenuated Vaccines Consumption by Countries (2013-2018)
  7.1.2 Europe Live Attenuated Vaccines Value by Countries (2013-2018)
7.2 Europe Live Attenuated Vaccines Consumption by Type
7.3 Europe Live Attenuated Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Live Attenuated Vaccines by Countries
  8.1.1 Middle East & Africa Live Attenuated Vaccines Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Live Attenuated Vaccines Value by Countries (2013-2018)
8.2 Middle East & Africa Live Attenuated Vaccines Consumption by Type
8.3 Middle East & Africa Live Attenuated Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Live Attenuated Vaccines Distributors
10.3 Live Attenuated Vaccines Customer

11 GLOBAL LIVE ATTENUATED VACCINES MARKET FORECAST

11.1 Global Live Attenuated Vaccines Consumption Forecast (2018-2023)
11.2 Global Live Attenuated Vaccines Forecast by Regions
  11.2.1 Global Live Attenuated Vaccines Forecast by Regions (2018-2023)
  11.2.2 Global Live Attenuated Vaccines Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Live Attenuated Vaccines Forecast by Type
11.8 Global Live Attenuated Vaccines Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 GlaxoSmithKline
  12.1.1 Company Details
  12.1.2 Live Attenuated Vaccines Product Offered
  12.1.3 GlaxoSmithKline Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 GlaxoSmithKline News
12.2 Merck
  12.2.1 Company Details
  12.2.2 Live Attenuated Vaccines Product Offered
  12.2.3 Merck Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Merck News
12.3 Pfizer
  12.3.1 Company Details
  12.3.2 Live Attenuated Vaccines Product Offered
  12.3.3 Pfizer Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Pfizer News
12.4 Astellas Pharma
  12.4.1 Company Details
  12.4.2 Live Attenuated Vaccines Product Offered
  12.4.3 Astellas Pharma Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Astellas Pharma News
12.5 Johnson & Johnson
  12.5.1 Company Details
  12.5.2 Live Attenuated Vaccines Product Offered
  12.5.3 Johnson & Johnson Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Johnson & Johnson News
12.6 CSL
  12.6.1 Company Details
  12.6.2 Live Attenuated Vaccines Product Offered
  12.6.3 CSL Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 CSL News
12.7 Sanofi
  12.7.1 Company Details
  12.7.2 Live Attenuated Vaccines Product Offered
  12.7.3 Sanofi Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Sanofi News
12.8 Serum Institute Of India
  12.8.1 Company Details
  12.8.2 Live Attenuated Vaccines Product Offered
  12.8.3 Serum Institute Of India Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Serum Institute Of India News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Live Attenuated Vaccines
Table Product Specifications of Live Attenuated Vaccines
Figure Live Attenuated Vaccines Report Years Considered
Figure Market Research Methodology
Figure Global Live Attenuated Vaccines Consumption Growth Rate 2013-2023 (K Units)
Figure Global Live Attenuated Vaccines Value Growth Rate 2013-2023 ($ Millions)
Table Live Attenuated Vaccines Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Bacterial
Table Major Players of Bacterial
Figure Product Picture of Viral
Table Major Players of Viral
Table Global Consumption Sales by Type (2013-2018)
Table Global Live Attenuated Vaccines Consumption Market Share by Type (2013-2018)
Figure Global Live Attenuated Vaccines Consumption Market Share by Type (2013-2018)
Table Global Live Attenuated Vaccines Revenue by Type (2013-2018) ($ million)
Table Global Live Attenuated Vaccines Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Live Attenuated Vaccines Value Market Share by Type (2013-2018)
Table Global Live Attenuated Vaccines Sale Price by Type (2013-2018)
Figure Live Attenuated Vaccines Consumed in Hospitals
Figure Global Live Attenuated Vaccines Market: Hospitals (2013-2018) (K Units)
Figure Global Live Attenuated Vaccines Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Live Attenuated Vaccines Consumed in Clinics
Figure Global Live Attenuated Vaccines Market: Clinics (2013-2018) (K Units)
Figure Global Live Attenuated Vaccines Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Live Attenuated Vaccines Consumed in Research Institutes
Figure Global Live Attenuated Vaccines Market: Research Institutes (2013-2018) (K Units)
Figure Global Live Attenuated Vaccines Market: Research Institutes (2013-2018) ($ Millions)
Figure Global Research Institutes YoY Growth ($ Millions)
Figure Live Attenuated Vaccines Consumed in Others
Figure Global Live Attenuated Vaccines Market: Others (2013-2018) (K Units)
Figure Global Live Attenuated Vaccines Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Live Attenuated Vaccines Consumption Market Share by Application (2013-2018)
Figure Global Live Attenuated Vaccines Consumption Market Share by Application (2013-2018)
Table Global Live Attenuated Vaccines Value by Application (2013-2018)
Table Global Live Attenuated Vaccines Value Market Share by Application (2013-2018)
Figure Global Live Attenuated Vaccines Value Market Share by Application (2013-2018)
Table Global Live Attenuated Vaccines Sale Price by Application (2013-2018)
Table Global Live Attenuated Vaccines Sales by Players (2016-2018) (K Units)
Table Global Live Attenuated Vaccines Sales Market Share by Players (2016-2018)
Figure Global Live Attenuated Vaccines Sales Market Share by Players in 2016
Figure Global Live Attenuated Vaccines Sales Market Share by Players in 2017
Table Global Live Attenuated Vaccines Revenue by Players (2016-2018) ($ Millions)
Table Global Live Attenuated Vaccines Revenue Market Share by Players (2016-2018)
Figure Global Live Attenuated Vaccines Revenue Market Share by Players in 2016
Figure Global Live Attenuated Vaccines Revenue Market Share by Players in 2017
Table Global Live Attenuated Vaccines Sale Price by Players (2016-2018)
Figure Global Live Attenuated Vaccines Sale Price by Players in 2017
Table Global Live Attenuated Vaccines Manufacturing Base Distribution and Sales Area by Players
Table Players Live Attenuated Vaccines Products Offered
Table Live Attenuated Vaccines Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Live Attenuated Vaccines Consumption by Regions 2013-2018 (K Units)
Table Global Live Attenuated Vaccines Consumption Market Share by Regions 2013-2018
Figure Global Live Attenuated Vaccines Consumption Market Share by Regions 2013-2018
Table Global Live Attenuated Vaccines Value by Regions 2013-2018 ($ Millions)
Table Global Live Attenuated Vaccines Value Market Share by Regions 2013-2018
Figure Global Live Attenuated Vaccines Value Market Share by Regions 2013-2018
Figure Americas Live Attenuated Vaccines Consumption 2013-2018 (K Units)
Figure Americas Live Attenuated Vaccines Value 2013-2018 ($ Millions)
Figure APAC Live Attenuated Vaccines Consumption 2013-2018 (K Units)
Figure APAC Live Attenuated Vaccines Value 2013-2018 ($ Millions)
Figure Europe Live Attenuated Vaccines Consumption 2013-2018 (K Units)
Figure Europe Live Attenuated Vaccines Value 2013-2018 ($ Millions)
Figure Middle East & Africa Live Attenuated Vaccines Consumption 2013-2018 (K Units)
Figure Middle East & Africa Live Attenuated Vaccines Value 2013-2018 ($ Millions)
Table Americas Live Attenuated Vaccines Consumption by Countries (2013-2018) (K Units)
Table Americas Live Attenuated Vaccines Consumption Market Share by Countries (2013-2018)
Figure Americas Live Attenuated Vaccines Consumption Market Share by Countries in 2017
Table Americas Live Attenuated Vaccines Value by Countries (2013-2018) ($ Millions)
Table Americas Live Attenuated Vaccines Value Market Share by Countries (2013-2018)
Figure Americas Live Attenuated Vaccines Value Market Share by Countries in 2017
Table Americas Live Attenuated Vaccines Consumption by Type (2013-2018) (K Units)
Table Americas Live Attenuated Vaccines Consumption Market Share by Type (2013-2018)
Figure Americas Live Attenuated Vaccines Consumption Market Share by Type in 2017
Table Americas Live Attenuated Vaccines Consumption by Application (2013-2018) (K Units)
Table Americas Live Attenuated Vaccines Consumption Market Share by Application (2013-2018)
Figure Americas Live Attenuated Vaccines Consumption Market Share by Application in 2017
Figure United States Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure United States Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Canada Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Canada Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Mexico Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Mexico Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Table APAC Live Attenuated Vaccines Consumption by Countries (2013-2018) (K Units)
Table APAC Live Attenuated Vaccines Consumption Market Share by Countries (2013-2018)
Figure APAC Live Attenuated Vaccines Consumption Market Share by Countries in 2017
Table APAC Live Attenuated Vaccines Value by Countries (2013-2018) ($ Millions)
Table APAC Live Attenuated Vaccines Value Market Share by Countries (2013-2018)
Figure APAC Live Attenuated Vaccines Value Market Share by Countries in 2017
Table APAC Live Attenuated Vaccines Consumption by Type (2013-2018) (K Units)
Table APAC Live Attenuated Vaccines Consumption Market Share by Type (2013-2018)
Figure APAC Live Attenuated Vaccines Consumption Market Share by Type in 2017
Table APAC Live Attenuated Vaccines Consumption by Application (2013-2018) (K Units)
Table APAC Live Attenuated Vaccines Consumption Market Share by Application (2013-2018)
Figure APAC Live Attenuated Vaccines Consumption Market Share by Application in 2017
Figure China Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure China Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Japan Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Japan Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Korea Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Korea Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure India Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure India Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Australia Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Australia Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Table Europe Live Attenuated Vaccines Consumption by Countries (2013-2018) (K Units)
Table Europe Live Attenuated Vaccines Consumption Market Share by Countries (2013-2018)
Figure Europe Live Attenuated Vaccines Consumption Market Share by Countries in 2017
Table Europe Live Attenuated Vaccines Value by Countries (2013-2018) ($ Millions)
Table Europe Live Attenuated Vaccines Value Market Share by Countries (2013-2018)
Figure Europe Live Attenuated Vaccines Value Market Share by Countries in 2017
Table Europe Live Attenuated Vaccines Consumption by Type (2013-2018) (K Units)
Table Europe Live Attenuated Vaccines Consumption Market Share by Type (2013-2018)
Figure Europe Live Attenuated Vaccines Consumption Market Share by Type in 2017
Table Europe Live Attenuated Vaccines Consumption by Application (2013-2018) (K Units)
Table Europe Live Attenuated Vaccines Consumption Market Share by Application (2013-2018)
Figure Europe Live Attenuated Vaccines Consumption Market Share by Application in 2017
Figure Germany Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Germany Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure France Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure France Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure UK Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure UK Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Italy Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Italy Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Russia Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Russia Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Spain Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Spain Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Live Attenuated Vaccines Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Live Attenuated Vaccines Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Live Attenuated Vaccines Consumption Market Share by Countries in 2017
Table Middle East & Africa Live Attenuated Vaccines Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Live Attenuated Vaccines Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Live Attenuated Vaccines Value Market Share by Countries in 2017
Table Middle East & Africa Live Attenuated Vaccines Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Live Attenuated Vaccines Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Live Attenuated Vaccines Consumption Market Share by Type in 2017
Table Middle East & Africa Live Attenuated Vaccines Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Live Attenuated Vaccines Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Live Attenuated Vaccines Consumption Market Share by Application in 2017
Figure Egypt Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Egypt Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure South Africa Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure South Africa Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Israel Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Israel Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure Turkey Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure Turkey Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Live Attenuated Vaccines Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Live Attenuated Vaccines Value Growth 2013-2018 ($ Millions)
Table Live Attenuated Vaccines Distributors List
Table Live Attenuated Vaccines Customer List
Figure Global Live Attenuated Vaccines Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Live Attenuated Vaccines Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Live Attenuated Vaccines Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Live Attenuated Vaccines Consumption Market Forecast by Regions
Table Global Live Attenuated Vaccines Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Live Attenuated Vaccines Value Market Share Forecast by Regions
Figure Americas Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Americas Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure APAC Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure APAC Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Europe Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Europe Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Middle East & Africa Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Middle East & Africa Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure United States Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure United States Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Canada Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Canada Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Mexico Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Mexico Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Brazil Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Brazil Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure China Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure China Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Japan Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Japan Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Korea Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Korea Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Southeast Asia Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Southeast Asia Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure India Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure India Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Australia Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Australia Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Germany Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Germany Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure France Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure France Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure UK Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure UK Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Italy Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Italy Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Russia Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Russia Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Spain Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Spain Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Egypt Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Egypt Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure South Africa Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure South Africa Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Israel Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Israel Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure Turkey Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure Turkey Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Figure GCC Countries Live Attenuated Vaccines Consumption 2018-2023 (K Units)
Figure GCC Countries Live Attenuated Vaccines Value 2018-2023 ($ Millions)
Table Global Live Attenuated Vaccines Consumption Forecast by Type (2018-2023) (K Units)
Table Global Live Attenuated Vaccines Consumption Market Share Forecast by Type (2018-2023)
Table Global Live Attenuated Vaccines Value Forecast by Type (2018-2023) ($ Millions)
Table Global Live Attenuated Vaccines Value Market Share Forecast by Type (2018-2023)
Table Global Live Attenuated Vaccines Consumption Forecast by Application (2018-2023) (K Units)
Table Global Live Attenuated Vaccines Consumption Market Share Forecast by Application (2018-2023)
Table Global Live Attenuated Vaccines Value Forecast by Application (2018-2023) ($ Millions)
Table Global Live Attenuated Vaccines Value Market Share Forecast by Application (2018-2023)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Live Attenuated Vaccines Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Live Attenuated Vaccines Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Live Attenuated Vaccines Market Share (2016-2018)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharma Live Attenuated Vaccines Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Live Attenuated Vaccines Market Share (2016-2018)
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSL Live Attenuated Vaccines Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Live Attenuated Vaccines Market Share (2016-2018)
Table Serum Institute Of India Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Institute Of India Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Serum Institute Of India Live Attenuated Vaccines Market Share (2016-2018)